Sveriges mest populära poddar
BioCentury This Week
VetenskapLife Science

Ep. 192 - Tier-jumpers: a Back to School Overview

33 min•5 september 2023

What are the criteria that enable companies to achieve the kind of success that leads to a jump in market cap tier? On the latest BioCentury This Week podcast, BioCentury’s editors discuss Back to School 2023, which examines the ingredients for building long-term, sustainable, high-value biotech companies.

Reach us by sending a text

Fler avsnitt av BioCentury This Week

Visa alla avsnitt av BioCentury This Week
Ep. 367 - FDA, obesity targets and the rise of DACs
•31 min
Ep. 366 - Europe's need for speed: Bio€quity takeaways
•44 min
Ep. 365 - Thin ice for Makary, redosing AAVs
•31 min
Ep. 364 - UCB’s Candid buy, Grand Rounds and leukodystrophies
•32 min
Ep. 363 - New targets at AACR, biopharma deals, Kurma fund
•30 min
Ep. 362 - AACR: Data and de-risking
•25 min
Ep. 361 - Kelonia, Kailera, pyschedelics and T cell engagers
•44 min
Ep. 360 - FDA’s FIH plans. Plus: billion-dollar deals, funds
•34 min
Ep. 359 - 2Q markets preview, tariffs and biotech takeouts
•39 min
Ep. 358 - Europe's biotech challenge
•24 min

BioCentury This Week med BioCentury finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.